Fentiazac

Fentiazac, alkanoic acid derivative, is an orally active non-steroidal anti-inflammatory agent, with analgesic, antipyretic and platelet anti-aggregation activity. Fentiazac can be used to research inflammatory diseases such as rheumatoid arthritis, osteoarthritis and tendinitis[1][2][3].

Product Specifications

CAS Number

[18046-21-4]

Product Name Alternative

PX-112,ABR-215757-d5-1; ABR 25757-d5-1,trans-PX-102,(-)-PX-102 (trans isomer); (-)-PX-104

UNSPSC

12352005

Hazard Statement

H302, H315, H319, H335

Target

COX

Type

Reference compound

Related Pathways

Immunology/Inflammation

Applications

COVID-19-immunoregulation

Field of Research

Inflammation/Immunology

Assay Protocol

https://www.medchemexpress.com/fentiazac.html

Purity

99.87

Solubility

DMSO : 100 mg/mL (ultrasonic)

Smiles

O=C(CC1=C(N=C(S1)C2=CC=CC=C2)C3=CC=C(C=C3)Cl)O

Molecular Formula

C17H12ClNO2S

Molecular Weight

329.81

Precautions

H302, H315, H319, H335

References & Citations

[1]Emilio Marmo, et al. Experimental and clinical pharmacology of fentiazac, a new, non-steroidal anti-inflammatory agent. Current Medical Research and Opinion.Volume 6, 1979 - Issue sup2.|[2]Gabor Katona, et al. Efficacy and tolerability of fentiazac in rheumatoid arthritis: Double-blind study versus indomethacin. Current Medical Research and Opinion. Volume 6, 1979 - Issue sup2.|[3]Famaey JP, Gaci O, Ginsberg F. Fentiazac in the treatment of osteoarthritis and tendinitis. Curr Med Res Opin. 1983;8 (9) :675-81.